The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice

Hiroko Tsutsui, Michiko Imamura, Jiro Fujimoto, +1

Gastroenterology Research and Practice

Contribution of TIR domain-containing adapter inducing IFN-β-mediated IL-18 release to LPS-induced liver injury in mice

Michiko Imamura, Hiroko Tsutsui, Koubun Yasuda, +11

Journal of Hepatology

InflammationCytokineCell SignalingLiver PhysiologyLps-induced Liver Injury +12

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel

Kazuhiro Araki, Yoshinori Ito, Ippei Fukada, +9

BMC Cancer

Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel

Yoshimasa Miyagawa, Kazuhiro Araki, Ayako Bun, +8

Clinical Breast Cancer

High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer

Arisa Nishimukai, Tomoko Yagi, Ayako Yanai, +8

Clinical Breast Cancer

Breast OncologyEndocrine-related CancerMedicinePathologyGynecology +8

Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes

Tomoko Higuchi, Arisa Nishimukai, Hiromi Ozawa, +9

The Breast

Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers

Takahiro Watanabe, Akira I. Hida, Natsuko Inoue, +5

Breast Cancer Research and Treatment

Breast OncologyMedicineImmunologyPathologyBreast Cancer +5

Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine

Michiko Imamura, Takashi Morimoto, Chiyomi Egawa, +7

Scientific Reports

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer

Ayako Yanai, Natsuko Inoue, Tomoko Yagi, +11

Clinical Breast Cancer

Breast OncologyHigh Ki-67MedicineReceptor Tyrosine KinaseBreast Cancer +7

Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers

Yukie Fujimoto, Takahiro Watanabe, Akira I. Hida, +9

Breast Cancer

Breast OncologyKi67 Expression LevelsMedicineImmunologyBreast Cancer +6